ClinicalTrials.gov
ClinicalTrials.gov Menu

The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00375388
Recruitment Status : Completed
First Posted : September 13, 2006
Last Update Posted : September 13, 2006
Sponsor:
Collaborators:
Takeda
LifeScan
Merck KGaA
Dupont Merck
Merck Sharp & Dohme Corp.
Novo Nordisk A/S
Information provided by:
Bethesda General Hospital, Hoogeveen